nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—CYP2C8—Nicotine—ulcerative colitis	0.117	0.344	CbGbCtD
Tazarotene—CYP2C8—Cholecalciferol—ulcerative colitis	0.105	0.308	CbGbCtD
Tazarotene—CYP2C8—Hydrocortisone—ulcerative colitis	0.0729	0.215	CbGbCtD
Tazarotene—CYP2C8—Dexamethasone—ulcerative colitis	0.0454	0.133	CbGbCtD
Tazarotene—RARG—Nuclear Receptors—NR5A2—ulcerative colitis	0.0112	0.0328	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors—NR5A2—ulcerative colitis	0.0101	0.0294	CbGpPWpGaD
Tazarotene—RXRB—Vitamin D Metabolism—VDR—ulcerative colitis	0.00979	0.0285	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—NR5A2—ulcerative colitis	0.00967	0.0282	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—NR5A2—ulcerative colitis	0.00967	0.0282	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—MST1—ulcerative colitis	0.00898	0.0262	CbGpPWpGaD
Tazarotene—Skin hyperpigmentation—Mercaptopurine—ulcerative colitis	0.00897	0.0283	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.00889	0.0259	CbGpPWpGaD
Tazarotene—Skin irritation—Budesonide—ulcerative colitis	0.00823	0.026	CcSEcCtD
Tazarotene—RARB—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.00797	0.0232	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.00764	0.0223	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.00764	0.0223	CbGpPWpGaD
Tazarotene—Burning sensation—Nicotine—ulcerative colitis	0.00744	0.0235	CcSEcCtD
Tazarotene—Application site irritation—Hydrocortisone—ulcerative colitis	0.00742	0.0234	CcSEcCtD
Tazarotene—Localized exfoliation—Triamcinolone—ulcerative colitis	0.0072	0.0227	CcSEcCtD
Tazarotene—Blister—Nicotine—ulcerative colitis	0.00717	0.0226	CcSEcCtD
Tazarotene—RARG—Nuclear Receptors—HNF4A—ulcerative colitis	0.00628	0.0183	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—LAMB1—ulcerative colitis	0.00623	0.0181	CbGpPWpGaD
Tazarotene—Acne—Nicotine—ulcerative colitis	0.00614	0.0194	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors—HNF4A—ulcerative colitis	0.00563	0.0164	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—HNF4A—ulcerative colitis	0.0054	0.0157	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—HNF4A—ulcerative colitis	0.0054	0.0157	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—VDR—ulcerative colitis	0.0053	0.0154	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.00496	0.0145	CbGpPWpGaD
Tazarotene—Leukoderma—Prednisolone—ulcerative colitis	0.00496	0.0157	CcSEcCtD
Tazarotene—Leukoderma—Hydrocortisone—ulcerative colitis	0.00484	0.0153	CcSEcCtD
Tazarotene—Skin irritation—Hydrocortisone—ulcerative colitis	0.00476	0.015	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—VDR—ulcerative colitis	0.00475	0.0139	CbGpPWpGaD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—VDR—ulcerative colitis	0.00473	0.0138	CbGpPWpGaD
Tazarotene—Application site pain—Hydrocortisone—ulcerative colitis	0.00468	0.0148	CcSEcCtD
Tazarotene—Leukoderma—Triamcinolone—ulcerative colitis	0.00456	0.0144	CcSEcCtD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—VDR—ulcerative colitis	0.00456	0.0133	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—VDR—ulcerative colitis	0.00456	0.0133	CbGpPWpGaD
Tazarotene—Leukoderma—Methylprednisolone—ulcerative colitis	0.00455	0.0144	CcSEcCtD
Tazarotene—RARB—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.00445	0.013	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.00429	0.0125	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.00428	0.0125	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.00427	0.0124	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.00427	0.0124	CbGpPWpGaD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—VDR—ulcerative colitis	0.00424	0.0124	CbGpPWpGaD
Tazarotene—Acne—Budesonide—ulcerative colitis	0.00423	0.0134	CcSEcCtD
Tazarotene—Burning sensation—Mesalazine—ulcerative colitis	0.00417	0.0132	CcSEcCtD
Tazarotene—Leukoderma—Betamethasone—ulcerative colitis	0.00414	0.0131	CcSEcCtD
Tazarotene—Leukoderma—Dexamethasone—ulcerative colitis	0.00414	0.0131	CcSEcCtD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—VDR—ulcerative colitis	0.00406	0.0118	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—VDR—ulcerative colitis	0.00406	0.0118	CbGpPWpGaD
Tazarotene—Blister—Mesalazine—ulcerative colitis	0.00402	0.0127	CcSEcCtD
Tazarotene—Dermatitis bullous—Nicotine—ulcerative colitis	0.00393	0.0124	CcSEcCtD
Tazarotene—RARG—Nuclear Receptors—VDR—ulcerative colitis	0.00391	0.0114	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.00384	0.0112	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.00384	0.0112	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—ulcerative colitis	0.0037	0.0108	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.00369	0.0107	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.00368	0.0107	CbGpPWpGaD
Tazarotene—Leukoderma—Prednisone—ulcerative colitis	0.0036	0.0114	CcSEcCtD
Tazarotene—Dermatitis contact—Budesonide—ulcerative colitis	0.00352	0.0111	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors—VDR—ulcerative colitis	0.00351	0.0102	CbGpPWpGaD
Tazarotene—Skin hyperpigmentation—Hydrocortisone—ulcerative colitis	0.00346	0.0109	CcSEcCtD
Tazarotene—Acne—Mesalazine—ulcerative colitis	0.00344	0.0109	CcSEcCtD
Tazarotene—RARA—Nuclear Receptors—VDR—ulcerative colitis	0.00336	0.0098	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—VDR—ulcerative colitis	0.00336	0.0098	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.00334	0.00974	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—ulcerative colitis	0.00331	0.00966	CbGpPWpGaD
Tazarotene—Skin hyperpigmentation—Triamcinolone—ulcerative colitis	0.00326	0.0103	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Methylprednisolone—ulcerative colitis	0.00325	0.0103	CcSEcCtD
Tazarotene—Skin discolouration—Mesalazine—ulcerative colitis	0.00321	0.0101	CcSEcCtD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—ulcerative colitis	0.00318	0.00926	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—ulcerative colitis	0.00318	0.00926	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.00309	0.00901	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—MIF—ulcerative colitis	0.00302	0.00879	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.003	0.00874	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.00298	0.00869	CbGpPWpGaD
Tazarotene—Skin hyperpigmentation—Betamethasone—ulcerative colitis	0.00296	0.00934	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Dexamethasone—ulcerative colitis	0.00296	0.00934	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.00295	0.00859	CbGpPWpGaD
Tazarotene—Swelling—Budesonide—ulcerative colitis	0.00293	0.00925	CcSEcCtD
Tazarotene—Blister—Prednisolone—ulcerative colitis	0.00292	0.00923	CcSEcCtD
Tazarotene—Eczema—Budesonide—ulcerative colitis	0.00288	0.00908	CcSEcCtD
Tazarotene—RXRB—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.00287	0.00837	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.00287	0.00837	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.00283	0.00823	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.00277	0.00808	CbGpPWpGaD
Tazarotene—Skin exfoliation—Mesalazine—ulcerative colitis	0.00276	0.00873	CcSEcCtD
Tazarotene—RARG—Nuclear Receptors—PPARG—ulcerative colitis	0.00273	0.00795	CbGpPWpGaD
Tazarotene—Blister—Triamcinolone—ulcerative colitis	0.00269	0.00849	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.00267	0.00779	CbGpPWpGaD
Tazarotene—Hypertriglyceridaemia—Prednisone—ulcerative colitis	0.00267	0.00842	CcSEcCtD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.00266	0.00775	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.00266	0.00775	CbGpPWpGaD
Tazarotene—Stinging—Prednisolone—ulcerative colitis	0.0026	0.00821	CcSEcCtD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.00256	0.00747	CbGpPWpGaD
Tazarotene—Oedema peripheral—Nicotine—ulcerative colitis	0.00256	0.00807	CcSEcCtD
Tazarotene—Stinging—Hydrocortisone—ulcerative colitis	0.00254	0.00802	CcSEcCtD
Tazarotene—Acne—Prednisolone—ulcerative colitis	0.00251	0.00791	CcSEcCtD
Tazarotene—Acne—Hydrocortisone—ulcerative colitis	0.00245	0.00772	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors—PPARG—ulcerative colitis	0.00245	0.00713	CbGpPWpGaD
Tazarotene—Blister—Betamethasone—ulcerative colitis	0.00244	0.0077	CcSEcCtD
Tazarotene—Blister—Dexamethasone—ulcerative colitis	0.00244	0.0077	CcSEcCtD
Tazarotene—Stinging—Triamcinolone—ulcerative colitis	0.00239	0.00755	CcSEcCtD
Tazarotene—RXRB—Nuclear Receptors—PPARG—ulcerative colitis	0.00235	0.00683	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—PPARG—ulcerative colitis	0.00235	0.00683	CbGpPWpGaD
Tazarotene—Eczema—Mesalazine—ulcerative colitis	0.00234	0.00738	CcSEcCtD
Tazarotene—Blood triglycerides increased—Prednisone—ulcerative colitis	0.00234	0.00738	CcSEcCtD
Tazarotene—Acne—Triamcinolone—ulcerative colitis	0.0023	0.00727	CcSEcCtD
Tazarotene—Acne—Methylprednisolone—ulcerative colitis	0.0023	0.00726	CcSEcCtD
Tazarotene—Skin discolouration—Hydrocortisone—ulcerative colitis	0.00228	0.0072	CcSEcCtD
Tazarotene—Erythema—Nicotine—ulcerative colitis	0.00226	0.00713	CcSEcCtD
Tazarotene—Dermatitis bullous—Mesalazine—ulcerative colitis	0.0022	0.00694	CcSEcCtD
Tazarotene—Stinging—Betamethasone—ulcerative colitis	0.00217	0.00685	CcSEcCtD
Tazarotene—Stinging—Dexamethasone—ulcerative colitis	0.00217	0.00685	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	0.00216	0.00628	CbGpPWpGaD
Tazarotene—Inflammation—Hydrocortisone—ulcerative colitis	0.00212	0.0067	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—ulcerative colitis	0.0021	0.00612	CbGpPWpGaD
Tazarotene—Acne—Betamethasone—ulcerative colitis	0.00209	0.0066	CcSEcCtD
Tazarotene—Acne—Dexamethasone—ulcerative colitis	0.00209	0.0066	CcSEcCtD
Tazarotene—Dermatitis contact—Hydrocortisone—ulcerative colitis	0.00203	0.00642	CcSEcCtD
Tazarotene—Inflammation—Methylprednisolone—ulcerative colitis	0.00199	0.00629	CcSEcCtD
Tazarotene—Skin exfoliation—Hydrocortisone—ulcerative colitis	0.00197	0.0062	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—ulcerative colitis	0.00196	0.00572	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—CDH1—ulcerative colitis	0.00195	0.00569	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	0.00193	0.00563	CbGpPWpGaD
Tazarotene—Dry skin—Mesalazine—ulcerative colitis	0.00193	0.00608	CcSEcCtD
Tazarotene—Dermatitis contact—Triamcinolone—ulcerative colitis	0.00192	0.00605	CcSEcCtD
Tazarotene—Oedema—Mercaptopurine—ulcerative colitis	0.0019	0.00601	CcSEcCtD
Tazarotene—Discomfort—Nicotine—ulcerative colitis	0.0019	0.006	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—ulcerative colitis	0.00189	0.00549	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	0.00185	0.0054	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	0.00185	0.0054	CbGpPWpGaD
Tazarotene—Skin exfoliation—Triamcinolone—ulcerative colitis	0.00185	0.00584	CcSEcCtD
Tazarotene—Skin exfoliation—Methylprednisolone—ulcerative colitis	0.00185	0.00583	CcSEcCtD
Tazarotene—Oedema—Nicotine—ulcerative colitis	0.00184	0.00582	CcSEcCtD
Tazarotene—Acne—Prednisone—ulcerative colitis	0.00182	0.00575	CcSEcCtD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—ulcerative colitis	0.00181	0.00527	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—ulcerative colitis	0.00181	0.00527	CbGpPWpGaD
Tazarotene—Haemoglobin—Budesonide—ulcerative colitis	0.0018	0.00567	CcSEcCtD
Tazarotene—Haemorrhage—Budesonide—ulcerative colitis	0.00179	0.00564	CcSEcCtD
Tazarotene—Oedema peripheral—Budesonide—ulcerative colitis	0.00176	0.00556	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—ulcerative colitis	0.00176	0.00513	CbGpPWpGaD
Tazarotene—Dermatitis contact—Betamethasone—ulcerative colitis	0.00174	0.00549	CcSEcCtD
Tazarotene—Dermatitis contact—Dexamethasone—ulcerative colitis	0.00174	0.00549	CcSEcCtD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—ulcerative colitis	0.00169	0.00492	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—ulcerative colitis	0.00169	0.00492	CbGpPWpGaD
Tazarotene—Skin exfoliation—Dexamethasone—ulcerative colitis	0.00168	0.0053	CcSEcCtD
Tazarotene—Skin exfoliation—Betamethasone—ulcerative colitis	0.00168	0.0053	CcSEcCtD
Tazarotene—Eczema—Hydrocortisone—ulcerative colitis	0.00166	0.00525	CcSEcCtD
Tazarotene—Photosensitivity reaction—Mesalazine—ulcerative colitis	0.00166	0.00523	CcSEcCtD
Tazarotene—RARG—Gene Expression—ZFP90—ulcerative colitis	0.00161	0.00469	CbGpPWpGaD
Tazarotene—Haemoglobin—Azathioprine—ulcerative colitis	0.0016	0.00506	CcSEcCtD
Tazarotene—Dermatitis bullous—Prednisolone—ulcerative colitis	0.0016	0.00505	CcSEcCtD
Tazarotene—Haemorrhage—Azathioprine—ulcerative colitis	0.0016	0.00504	CcSEcCtD
Tazarotene—Pain—Nicotine—ulcerative colitis	0.00158	0.00498	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	0.00155	0.00451	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.00153	0.00447	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	0.00148	0.00433	CbGpPWpGaD
Tazarotene—Dermatitis bullous—Triamcinolone—ulcerative colitis	0.00147	0.00465	CcSEcCtD
Tazarotene—Skin exfoliation—Prednisone—ulcerative colitis	0.00146	0.00462	CcSEcCtD
Tazarotene—Haemoglobin—Mesalazine—ulcerative colitis	0.00146	0.00461	CcSEcCtD
Tazarotene—Haemorrhage—Mesalazine—ulcerative colitis	0.00145	0.00459	CcSEcCtD
Tazarotene—RARB—Gene Expression—ZFP90—ulcerative colitis	0.00144	0.00421	CbGpPWpGaD
Tazarotene—Oedema peripheral—Mesalazine—ulcerative colitis	0.00143	0.00452	CcSEcCtD
Tazarotene—Dry skin—Prednisolone—ulcerative colitis	0.0014	0.00443	CcSEcCtD
Tazarotene—RARA—Gene Expression—ZFP90—ulcerative colitis	0.00138	0.00403	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—ZFP90—ulcerative colitis	0.00138	0.00403	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.00138	0.00401	CbGpPWpGaD
Tazarotene—Dry skin—Hydrocortisone—ulcerative colitis	0.00137	0.00432	CcSEcCtD
Tazarotene—Dermatitis bullous—Dexamethasone—ulcerative colitis	0.00134	0.00422	CcSEcCtD
Tazarotene—Dermatitis bullous—Betamethasone—ulcerative colitis	0.00134	0.00422	CcSEcCtD
Tazarotene—RARA—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.00132	0.00385	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.00132	0.00385	CbGpPWpGaD
Tazarotene—Discomfort—Budesonide—ulcerative colitis	0.00131	0.00413	CcSEcCtD
Tazarotene—Pruritus—Nicotine—ulcerative colitis	0.0013	0.00412	CcSEcCtD
Tazarotene—Erythema—Mesalazine—ulcerative colitis	0.00127	0.004	CcSEcCtD
Tazarotene—Rash—Mercaptopurine—ulcerative colitis	0.0012	0.00379	CcSEcCtD
Tazarotene—Dermatitis—Mercaptopurine—ulcerative colitis	0.0012	0.00378	CcSEcCtD
Tazarotene—Dry skin—Dexamethasone—ulcerative colitis	0.00117	0.00369	CcSEcCtD
Tazarotene—Dry skin—Betamethasone—ulcerative colitis	0.00117	0.00369	CcSEcCtD
Tazarotene—Discomfort—Azathioprine—ulcerative colitis	0.00117	0.00369	CcSEcCtD
Tazarotene—Rash—Nicotine—ulcerative colitis	0.00116	0.00367	CcSEcCtD
Tazarotene—Dermatitis—Nicotine—ulcerative colitis	0.00116	0.00367	CcSEcCtD
Tazarotene—Pain—Budesonide—ulcerative colitis	0.00109	0.00343	CcSEcCtD
Tazarotene—Discomfort—Mesalazine—ulcerative colitis	0.00106	0.00336	CcSEcCtD
Tazarotene—Haemoglobin—Prednisolone—ulcerative colitis	0.00106	0.00336	CcSEcCtD
Tazarotene—Haemorrhage—Prednisolone—ulcerative colitis	0.00106	0.00334	CcSEcCtD
Tazarotene—Haemoglobin—Hydrocortisone—ulcerative colitis	0.00104	0.00328	CcSEcCtD
Tazarotene—Haemorrhage—Hydrocortisone—ulcerative colitis	0.00103	0.00326	CcSEcCtD
Tazarotene—Oedema—Mesalazine—ulcerative colitis	0.00103	0.00326	CcSEcCtD
Tazarotene—Dry skin—Prednisone—ulcerative colitis	0.00102	0.00322	CcSEcCtD
Tazarotene—Haemoglobin—Triamcinolone—ulcerative colitis	0.000979	0.00309	CcSEcCtD
Tazarotene—Haemoglobin—Methylprednisolone—ulcerative colitis	0.000976	0.00308	CcSEcCtD
Tazarotene—Haemorrhage—Triamcinolone—ulcerative colitis	0.000974	0.00307	CcSEcCtD
Tazarotene—Haemorrhage—Methylprednisolone—ulcerative colitis	0.000971	0.00307	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	0.000966	0.00282	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	0.000926	0.0027	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000924	0.00269	CbGpPWpGaD
Tazarotene—Erythema—Prednisolone—ulcerative colitis	0.000922	0.00291	CcSEcCtD
Tazarotene—Erythema—Hydrocortisone—ulcerative colitis	0.0009	0.00284	CcSEcCtD
Tazarotene—Pruritus—Budesonide—ulcerative colitis	0.000899	0.00284	CcSEcCtD
Tazarotene—Haemoglobin—Dexamethasone—ulcerative colitis	0.000888	0.0028	CcSEcCtD
Tazarotene—Haemoglobin—Betamethasone—ulcerative colitis	0.000888	0.0028	CcSEcCtD
Tazarotene—Pain—Mesalazine—ulcerative colitis	0.000883	0.00279	CcSEcCtD
Tazarotene—Haemorrhage—Betamethasone—ulcerative colitis	0.000883	0.00279	CcSEcCtD
Tazarotene—Haemorrhage—Dexamethasone—ulcerative colitis	0.000883	0.00279	CcSEcCtD
Tazarotene—RARA—Adipogenesis—PPARG—ulcerative colitis	0.000877	0.00255	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—HNF4A—ulcerative colitis	0.000858	0.0025	CbGpPWpGaD
Tazarotene—Erythema—Triamcinolone—ulcerative colitis	0.000848	0.00268	CcSEcCtD
Tazarotene—Erythema—Methylprednisolone—ulcerative colitis	0.000846	0.00267	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—MAML2—ulcerative colitis	0.000836	0.00243	CbGpPWpGaD
Tazarotene—Rash—Budesonide—ulcerative colitis	0.000801	0.00253	CcSEcCtD
Tazarotene—Dermatitis—Budesonide—ulcerative colitis	0.0008	0.00253	CcSEcCtD
Tazarotene—Discomfort—Prednisolone—ulcerative colitis	0.000775	0.00245	CcSEcCtD
Tazarotene—Haemoglobin—Prednisone—ulcerative colitis	0.000773	0.00244	CcSEcCtD
Tazarotene—Haemorrhage—Prednisone—ulcerative colitis	0.000769	0.00243	CcSEcCtD
Tazarotene—RARB—Generic Transcription Pathway—HNF4A—ulcerative colitis	0.000769	0.00224	CbGpPWpGaD
Tazarotene—Erythema—Dexamethasone—ulcerative colitis	0.000769	0.00243	CcSEcCtD
Tazarotene—Erythema—Betamethasone—ulcerative colitis	0.000769	0.00243	CcSEcCtD
Tazarotene—Discomfort—Hydrocortisone—ulcerative colitis	0.000757	0.00239	CcSEcCtD
Tazarotene—Oedema—Prednisolone—ulcerative colitis	0.000752	0.00237	CcSEcCtD
Tazarotene—RARB—Generic Transcription Pathway—MAML2—ulcerative colitis	0.00075	0.00218	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NR5A2—ulcerative colitis	0.000739	0.00215	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—HNF4A—ulcerative colitis	0.000737	0.00215	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—HNF4A—ulcerative colitis	0.000737	0.00215	CbGpPWpGaD
Tazarotene—Oedema—Hydrocortisone—ulcerative colitis	0.000735	0.00232	CcSEcCtD
Tazarotene—Pruritus—Mesalazine—ulcerative colitis	0.000731	0.00231	CcSEcCtD
Tazarotene—RARA—Generic Transcription Pathway—MAML2—ulcerative colitis	0.000719	0.00209	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—MAML2—ulcerative colitis	0.000719	0.00209	CbGpPWpGaD
Tazarotene—Rash—Azathioprine—ulcerative colitis	0.000715	0.00226	CcSEcCtD
Tazarotene—Dermatitis—Azathioprine—ulcerative colitis	0.000714	0.00226	CcSEcCtD
Tazarotene—Discomfort—Triamcinolone—ulcerative colitis	0.000713	0.00225	CcSEcCtD
Tazarotene—Discomfort—Methylprednisolone—ulcerative colitis	0.000711	0.00225	CcSEcCtD
Tazarotene—Oedema—Triamcinolone—ulcerative colitis	0.000692	0.00218	CcSEcCtD
Tazarotene—Erythema—Prednisone—ulcerative colitis	0.00067	0.00211	CcSEcCtD
Tazarotene—RARB—Gene Expression—NR5A2—ulcerative colitis	0.000663	0.00193	CbGpPWpGaD
Tazarotene—Rash—Mesalazine—ulcerative colitis	0.000651	0.00206	CcSEcCtD
Tazarotene—Dermatitis—Mesalazine—ulcerative colitis	0.000651	0.00205	CcSEcCtD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000648	0.00189	CbGpPWpGaD
Tazarotene—Discomfort—Betamethasone—ulcerative colitis	0.000647	0.00204	CcSEcCtD
Tazarotene—Discomfort—Dexamethasone—ulcerative colitis	0.000647	0.00204	CcSEcCtD
Tazarotene—Pain—Prednisolone—ulcerative colitis	0.000643	0.00203	CcSEcCtD
Tazarotene—RXRB—Gene Expression—NR5A2—ulcerative colitis	0.000635	0.00185	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NR5A2—ulcerative colitis	0.000635	0.00185	CbGpPWpGaD
Tazarotene—Pain—Hydrocortisone—ulcerative colitis	0.000628	0.00198	CcSEcCtD
Tazarotene—Oedema—Dexamethasone—ulcerative colitis	0.000628	0.00198	CcSEcCtD
Tazarotene—Oedema—Betamethasone—ulcerative colitis	0.000628	0.00198	CcSEcCtD
Tazarotene—Pain—Triamcinolone—ulcerative colitis	0.000592	0.00187	CcSEcCtD
Tazarotene—Discomfort—Prednisone—ulcerative colitis	0.000563	0.00178	CcSEcCtD
Tazarotene—Oedema—Prednisone—ulcerative colitis	0.000547	0.00173	CcSEcCtD
Tazarotene—RARA—Adipogenesis—STAT3—ulcerative colitis	0.000538	0.00157	CbGpPWpGaD
Tazarotene—Pain—Dexamethasone—ulcerative colitis	0.000537	0.00169	CcSEcCtD
Tazarotene—Pain—Betamethasone—ulcerative colitis	0.000537	0.00169	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—VDR—ulcerative colitis	0.000534	0.00156	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	0.000529	0.00154	CbGpPWpGaD
Tazarotene—Pruritus—Hydrocortisone—ulcerative colitis	0.00052	0.00164	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	0.000507	0.00148	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TGFB1—ulcerative colitis	0.000499	0.00145	CbGpPWpGaD
Tazarotene—Pruritus—Triamcinolone—ulcerative colitis	0.000489	0.00154	CcSEcCtD
Tazarotene—Pruritus—Methylprednisolone—ulcerative colitis	0.000488	0.00154	CcSEcCtD
Tazarotene—RARB—Generic Transcription Pathway—VDR—ulcerative colitis	0.000479	0.0014	CbGpPWpGaD
Tazarotene—Rash—Prednisolone—ulcerative colitis	0.000474	0.0015	CcSEcCtD
Tazarotene—Dermatitis—Prednisolone—ulcerative colitis	0.000474	0.0015	CcSEcCtD
Tazarotene—RARA—Adipogenesis—TNF—ulcerative colitis	0.000466	0.00136	CbGpPWpGaD
Tazarotene—Rash—Hydrocortisone—ulcerative colitis	0.000463	0.00146	CcSEcCtD
Tazarotene—Dermatitis—Hydrocortisone—ulcerative colitis	0.000463	0.00146	CcSEcCtD
Tazarotene—RXRB—Generic Transcription Pathway—VDR—ulcerative colitis	0.000459	0.00134	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—VDR—ulcerative colitis	0.000459	0.00134	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	0.000459	0.00134	CbGpPWpGaD
Tazarotene—Pruritus—Dexamethasone—ulcerative colitis	0.000444	0.0014	CcSEcCtD
Tazarotene—Pruritus—Betamethasone—ulcerative colitis	0.000444	0.0014	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	0.00044	0.00128	CbGpPWpGaD
Tazarotene—Rash—Triamcinolone—ulcerative colitis	0.000436	0.00138	CcSEcCtD
Tazarotene—Dermatitis—Triamcinolone—ulcerative colitis	0.000436	0.00138	CcSEcCtD
Tazarotene—Rash—Methylprednisolone—ulcerative colitis	0.000435	0.00137	CcSEcCtD
Tazarotene—Dermatitis—Methylprednisolone—ulcerative colitis	0.000435	0.00137	CcSEcCtD
Tazarotene—RARG—Gene Expression—HNF4A—ulcerative colitis	0.000413	0.0012	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MAML2—ulcerative colitis	0.000402	0.00117	CbGpPWpGaD
Tazarotene—Rash—Betamethasone—ulcerative colitis	0.000396	0.00125	CcSEcCtD
Tazarotene—Rash—Dexamethasone—ulcerative colitis	0.000396	0.00125	CcSEcCtD
Tazarotene—Dermatitis—Dexamethasone—ulcerative colitis	0.000395	0.00125	CcSEcCtD
Tazarotene—Dermatitis—Betamethasone—ulcerative colitis	0.000395	0.00125	CcSEcCtD
Tazarotene—Pruritus—Prednisone—ulcerative colitis	0.000387	0.00122	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	0.000382	0.00111	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IL6—ulcerative colitis	0.000376	0.00109	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—PPARG—ulcerative colitis	0.000372	0.00108	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HNF4A—ulcerative colitis	0.00037	0.00108	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	0.000367	0.00107	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MAML2—ulcerative colitis	0.000361	0.00105	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	0.000357	0.00104	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HNF4A—ulcerative colitis	0.000355	0.00103	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HNF4A—ulcerative colitis	0.000355	0.00103	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000354	0.00103	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MAML2—ulcerative colitis	0.000346	0.00101	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MAML2—ulcerative colitis	0.000346	0.00101	CbGpPWpGaD
Tazarotene—Rash—Prednisone—ulcerative colitis	0.000345	0.00109	CcSEcCtD
Tazarotene—Dermatitis—Prednisone—ulcerative colitis	0.000344	0.00109	CcSEcCtD
Tazarotene—CYP2C8—Biological oxidations—PTGS1—ulcerative colitis	0.000344	0.001	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	0.000342	0.000997	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—PPARG—ulcerative colitis	0.000334	0.000973	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—PPARG—ulcerative colitis	0.00032	0.000933	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—PPARG—ulcerative colitis	0.00032	0.000933	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	0.000315	0.000917	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	0.000302	0.000879	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—VDR—ulcerative colitis	0.000257	0.000749	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—VDR—ulcerative colitis	0.000231	0.000672	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—VDR—ulcerative colitis	0.000221	0.000644	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—VDR—ulcerative colitis	0.000221	0.000644	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPARG—ulcerative colitis	0.000179	0.000522	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPARG—ulcerative colitis	0.000161	0.000468	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPARG—ulcerative colitis	0.000154	0.000449	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPARG—ulcerative colitis	0.000154	0.000449	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CHP1—ulcerative colitis	0.000141	0.000411	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.000132	0.000385	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—DLD—ulcerative colitis	0.000122	0.000355	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.43e-05	0.000187	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS1—ulcerative colitis	5.88e-05	0.000171	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.79e-05	0.000169	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CALM3—ulcerative colitis	5.3e-05	0.000154	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.06e-05	0.000147	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCB1—ulcerative colitis	4.12e-05	0.00012	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ADCY5—ulcerative colitis	3.84e-05	0.000112	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARG—ulcerative colitis	2.87e-05	8.35e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALB—ulcerative colitis	2.58e-05	7.51e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS2—ulcerative colitis	2.25e-05	6.57e-05	CbGpPWpGaD
